A Roller Coaster Ride of M&A: Case Study of Sun Pharmaceuticals Industries Limited & Taro Pharmaceuticals Industries Limited
Shri Chimanbhai Patel Institutes Working Paper No. CPI/MBA/2013/0001
16 Pages Posted: 8 Jan 2013 Last revised: 30 Jul 2014
Date Written: January 8, 2013
This is one wrestle which has rocked the two crown establishments in pharma space and has taken them through a roller coaster ride. The battalion of group companies for one of India’s leading drug maker Sun Pharmaceutical Industries Limited would have swiftly expanded to include another gigantic drug making company of Israel i.e. Taro Pharmaceutical Industries Limited. At the outset of entering into a concord for a friendly merger between Sun Pharmaceutical Industries Limited (India) and Taro Pharmaceuticals Industries Limited (Israel) (the “Proposed Transaction”), none of the parties would have contemplated that they would end up battling in courts or trying to settle the disputes through mediation. Manifestly, what was supposed to be the second largest outbound acquisition by an Indian company in the pharmacy space is now into disputed waters.
This M&A Case probes the commercial, legal, tax and regulatory aspects of the Proposed Transaction between Sun Pharmaceutical Industries Limited and Taro Pharmaceuticals Industries Limited.
Keywords: mergers and acquisition, corporate restructuring, commercial, legal, tax, regulatory, pharma
JEL Classification: G34, G38
Suggested Citation: Suggested Citation